Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with HeritableOCT1Deficiency-Reference-Cited by-同舟云学术

Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with HeritableOCT1Deficiency

Published:2017-12-08 Issue:5 Volume:103 Page:868-878
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Tzvetkov Mladen V.¹,Matthaei Johannes¹,Pojar Sherin¹,Faltraco Frank,Vogler Sabrina¹,Prukop Thomas¹,Seitz Tina¹,Brockmöller Jürgen¹

Affiliation:

1. Institute for Clinical Pharmacology; University Medical Center Göttingen; Göttingen Germany

Funder

German Research Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.812/fullpdf

Reference37 articles.

1. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study;Crane;Lancet,1989

2. End of the New Zealand asthma mortality epidemic;Pearce;Lancet,1995

3. The use of beta-agonists and the risk of death and near death from asthma;Spitzer;N. Engl. J. Med.,1992

4. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol;Bremner;Eur. Respir. J.,1993

5. Gellermann , H.J. Hoffmann , H. Dear Doctor Letter (Rote-Hand-Brief) on short-acting beta-agonists/beta 2-sympathomimetic agents (SABAs) for obstetric indications - including Partusisten® (fenoterol): restrictions of indication https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/EN/RHB/2013/rhb-partusisten.html 2013

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3;Journal of Medicinal Chemistry;2023-12-05

2. Structural basis of promiscuous substrate transport by Organic Cation Transporter 1;Nature Communications;2023-10-11

3. Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2;Nature Structural & Molecular Biology;2023-06-08

4. The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics;2023-06-07

5. Combined and independent effects of OCT1 and CYP2D6 on the cellular disposition of drugs;Biomedicine & Pharmacotherapy;2023-05